Literature DB >> 18684670

Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis.

Kimberly A Powers1, Charles Poole, Audrey E Pettifor, Myron S Cohen.   

Abstract

Studies of cumulative HIV incidence suggest that cofactors such as genital ulcer disease, HIV disease stage, and male circumcision influence HIV transmission; however, the heterosexual infectivity of HIV-1 is commonly cited as a fixed value (approximately 0.001, or one transmission per 1000 contacts). We sought to estimate transmission cofactor effects on the heterosexual infectivity of HIV-1 and to quantify the extent to which study methods have affected infectivity estimates. We undertook a systematic search (up to April 27, 2008) of PubMed, Web of Science, and relevant bibliographies to identify articles estimating the heterosexual infectivity of HIV-1. We used meta-regression and stratified random-effects meta-analysis to assess differences in infectivity associated with cofactors and study methods. Infectivity estimates were very heterogeneous, ranging from zero transmissions after more than 100 penile-vaginal contacts in some serodiscordant couples to one transmission for every 3.1 episodes of heterosexual anal intercourse. Estimates were only weakly associated with study methods. Infectivity differences, expressed as number of transmissions per 1000 contacts, were 8.1 (95 % CI 0.4-15.8) when comparing uncircumcised to circumcised susceptible men, 6.0 (3.3-8.8) comparing susceptible individuals with and without genital ulcer disease, 1.9 (0.9-2.8) comparing late-stage to mid-stage index cases, and 2.5 (0.2-4.9) comparing early-stage to mid-stage index cases. A single value for the heterosexual infectivity of HIV-1 fails to reflect the variation associated with important cofactors. The commonly cited value of 0.001 was estimated among stable couples with low prevalences of high-risk cofactors, and represents a lower bound. Cofactor effects are important to include in epidemic models, policy considerations, and prevention messages.

Entities:  

Mesh:

Year:  2008        PMID: 18684670      PMCID: PMC2744983          DOI: 10.1016/S1473-3099(08)70156-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  70 in total

1.  Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections.

Authors:  T A Peterman; R L Stoneburner; J R Allen; H W Jaffe; J W Curran
Journal:  JAMA       Date:  1988-01-01       Impact factor: 56.272

2.  Infectivity of the human immunodeficiency virus: estimates from a prospective study of homosexual men.

Authors:  R M Grant; J A Wiley; W Winkelstein
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

3.  Heterogeneity in the probability of HIV transmission per sexual contact: the case of male-to-female transmission in penile-vaginal intercourse.

Authors:  J A Wiley; S J Herschkorn; N S Padian
Journal:  Stat Med       Date:  1989-01       Impact factor: 2.373

4.  Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV.

Authors:  A M Downs; I De Vincenzi
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-04-01

5.  Male-to-female transmission of human immunodeficiency virus.

Authors:  N Padian; L Marquis; D P Francis; R E Anderson; G W Rutherford; P M O'Malley; W Winkelstein
Journal:  JAMA       Date:  1987-08-14       Impact factor: 56.272

6.  Evaluation of heterosexual partners, children, and household contacts of adults with AIDS.

Authors:  M A Fischl; G M Dickinson; G B Scott; N Klimas; M A Fletcher; W Parks
Journal:  JAMA       Date:  1987-02-06       Impact factor: 56.272

7.  Modelling the female-to-male per-act HIV transmission probability in an emerging epidemic in Asia.

Authors:  G A Satten; T D Mastro; I M Longini
Journal:  Stat Med       Date:  1994 Oct 15-30       Impact factor: 2.373

8.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial.

Authors:  H Grosskurth; F Mosha; J Todd; E Mwijarubi; A Klokke; K Senkoro; P Mayaud; J Changalucha; A Nicoll; G ka-Gina
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

Review 9.  The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa.

Authors:  R J Hayes; K F Schulz; F A Plummer
Journal:  J Trop Med Hyg       Date:  1995-02

Review 10.  Biologic factors in the sexual transmission of human immunodeficiency virus.

Authors:  S D Holmberg; C R Horsburgh; J W Ward; H W Jaffe
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

View more
  158 in total

1.  It is too early to discuss HIV elimination.

Authors:  David P Wilson; Sean R Hosein
Journal:  Public Health Rep       Date:  2010 Nov-Dec       Impact factor: 2.792

2.  Antiretroviral therapy as HIV prevention: status and prospects.

Authors:  Kenneth H Mayer; Kartik K Venkatesh
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

3.  SPMM: estimating infection duration of multivariant HIV-1 infections.

Authors:  Tanzy M T Love; Sung Yong Park; Elena E Giorgi; Wendy J Mack; Alan S Perelson; Ha Youn Lee
Journal:  Bioinformatics       Date:  2015-12-31       Impact factor: 6.937

Review 4.  Treating Posttraumatic Stress Symptoms Among People Living with HIV: a Critical Review of Intervention Trials.

Authors:  Carmen P McLean; Hayley Fitzgerald
Journal:  Curr Psychiatry Rep       Date:  2016-09       Impact factor: 5.285

5.  Heterosexual anal intercourse among men in Long Beach, California.

Authors:  Kristen L Hess; Grace L Reynolds; Dennis G Fisher
Journal:  J Sex Res       Date:  2013-09-11

6.  Concurrent sexual partnerships and primary HIV infection: a critical interaction.

Authors:  Jeffrey W Eaton; Timothy B Hallett; Geoffrey P Garnett
Journal:  AIDS Behav       Date:  2011-05

Review 7.  Vaginal microbicides and the prevention of HIV transmission.

Authors:  Blayne Cutler; Jessica Justman
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

8.  Understanding the modes of transmission model of new HIV infection and its use in prevention planning.

Authors:  Kelsey K Case; Peter D Ghys; Eleanor Gouws; Jeffrey W Eaton; Annick Borquez; John Stover; Paloma Cuchi; Laith J Abu-Raddad; Geoffrey P Garnett; Timothy B Hallett
Journal:  Bull World Health Organ       Date:  2012-09-14       Impact factor: 9.408

9.  A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.

Authors:  Christophe Vanpouille; Andrea Lisco; Marco Derudas; Elisa Saba; Jean-Charles Grivel; Beda Brichacek; Francesca Scrimieri; Raymond Schinazi; Dominique Schols; Christopher McGuigan; Jan Balzarini; Leonid Margolis
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

10.  Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review.

Authors:  Jennifer LeMessurier; Gregory Traversy; Olivia Varsaneux; Makenzie Weekes; Marc T Avey; Oscar Niragira; Robert Gervais; Gordon Guyatt; Rachel Rodin
Journal:  CMAJ       Date:  2018-11-19       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.